One may expect the relationship between transcriptionally active HIF-1 and Bid to be independent of these mechanisms, but other regulators of Bid expression (e.g., p53 loss) (Sax et al, 2002) may also be operational in CRC tissue. Here, TP53 is linked to colorectal carcinoma.